Skip to content
Parakho

Akums Drugs and Pharmaceuticals Ltd

NSE AKUMSBSE 544222akums.inInvestor relations

Q1 FY27, unaudited

Revenue
₹1,166.63 Cr
Profit after tax
₹100.98 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations1,166.63+13.93%4,359.02
Other income30.38+13.65%128.73
Total income1,197.01+13.92%4,487.74
Employee benefit expense201.43+14.36%753.82
Finance costs24.76+7.01%94.07
Depreciation & amortisation41.07+11.23%154.55
Total expenses1,057.77+10.75%4,085.62
Profit before tax139.24+45.58%382.10
Tax expense38.26+23.57%125.70
Profit after tax100.98+56.11%256.40
Total comprehensive income104.09+56.70%257.32
Earnings per share
Earnings per share, basic₹6.53₹16.67
Earnings per share, diluted₹6.53₹16.67

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — unaudited, from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Akums Drugs & Pharmaceuticals reported Q1 FY27 revenue of Rs 1,167 crores, up 13.9% year-on-year, with EBITDA of Rs 175 crores, up 35.4% year-on-year, driven primarily by the CDMO segment. Management said domestic and international branded formulation segments saw muted quarterly performances while API and trade generics segments performed in line with prior guidance. The company also announced the acquisition of Oriflame India's manufacturing business, covering facilities in Roorkee and Noida, to expand into skin care cosmetics and wellness products.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 60 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 09 Oct 2026.

Akums Drugs and Pharmaceuticals Ltd (AKUMS) Q1 FY27 results — revenue, profit and filings · Parakho